Insider · CIK 0001190283
Christopher J McGurk
Files at CNVS (Cineverse Corp.). First filing Feb 17, 2026, latest Feb 17, 2026.
In brief
Christopher J McGurk files SEC Form 4 as CEO, chair and director at CNVS (Cineverse Corp.). Since Feb 17, 2026, Christopher J McGurk has reported 1 open-market buy worth $150k and 0 open-market sells worth $0, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Christopher J McGurk has 0, so none is measured yet.
The newest scored trade: bought $150k of CNVS on Feb 17, 2026, filed Feb 17, 2026, scored 69 (notable). In the last 12 months: 1 buy worth $150k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CNVS: Cineverse Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 69Notable | Cineverse Corp. | $150k 75,000 shares | +72% | +48% from low-62% from high |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +87,669 | - | - | 670,188 | 2 h ago |
| Oct 8, 2026 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -87,669 | $0.00 | $0 | 175,337 | 2 h ago |
| May 1, 2026 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +40,000 | - | - | 582,519 | May 5, 2026 |
| May 1, 2026 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -40,000 | $0.00 | $0 | 80,000 | May 5, 2026 |
| Apr 25, 2026 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +50,000 | - | - | 542,519 | Apr 28, 2026 |
| Apr 25, 2026 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -50,000 | $0.00 | $0 | 50,000 | Apr 28, 2026 |
| Feb 17, 2026 | CNVS Cineverse Corp. | POpen-market purchase Class A Common Stockindirect: By Christopher and Jamie McGurk Living Trust | +75,000 | $2.00 | $150k | 178,526 | Feb 17, 2026 |
| Oct 8, 2025 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +263,006 | $0.00 | $0 | 263,006 | Oct 10, 2025 |
| May 1, 2025 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +120,000 | $0.00 | $0 | 120,000 | May 5, 2025 |
| Apr 25, 2025 | CNVS Cineverse Corp. | MOption exercise Class A Common Stock | +50,000 | - | - | 342,519 | Apr 29, 2025 |
| Apr 25, 2025 | CNVS Cineverse Corp. | MOption exercise Restricted Stock Unitderivative | -50,000 | $0.00 | $0 | 100,000 | Apr 29, 2025 |
| Apr 25, 2024 | CNVS Cineverse Corp. | AGrant or award Class A Common Stock | +150,000 | $0.00 | $0 | 442,519 | Apr 26, 2024 |
| Apr 25, 2024 | CNVS Cineverse Corp. | AGrant or award Restricted Stock Unitderivative | +150,000 | $0.00 | $0 | 150,000 | Apr 26, 2024 |
Questions about Christopher J McGurk
Answered from the filings on this page, as of the latest one.
Is Christopher J McGurk buying or selling?
In the last 12 months Christopher J McGurk reported 1 open-market buy worth $150k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $150k of CNVS on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Christopher J McGurk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher J McGurk has 0.
Where does Christopher J McGurk file Form 4?
Christopher J McGurk has filed Form 4 at CNVS (Cineverse Corp.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.